Cannabis Terpenes And CBD Outperform Leading COVID-19 Treatment In Early Trial

This article was originally published on The Fresh Toast, and appears here with permission.

A combination of CBD and terpenes was three time more effective in stopping coronavirus-related inflammation run amok compared to dexamethasone.

Public health officials have lamented the rush to locate a reliable Covid-19 treatment has led to “desperation science,” marked by maverick experimentation and faulty research. And while skeptics may lump cannabis in with that description, early trial results indicate otherwise.

We previously reported that several Israeli companies were exploring what role CBD and cannabis terpenes could play in fighting the coronavirus. Researchers reported that CBD’s anti-inflammatory and anti-viral properties might provide key …

Full story available on Benzinga.com

More Cannabis Terpenes And CBD Outperform Leading COVID-19 Treatment In Early Trial